HK1203512A1 - Compounds and methods for the treatment of cancer - Google Patents

Compounds and methods for the treatment of cancer Download PDF

Info

Publication number
HK1203512A1
HK1203512A1 HK15103803.4A HK15103803A HK1203512A1 HK 1203512 A1 HK1203512 A1 HK 1203512A1 HK 15103803 A HK15103803 A HK 15103803A HK 1203512 A1 HK1203512 A1 HK 1203512A1
Authority
HK
Hong Kong
Prior art keywords
cancer
compound
alkyl
amine
aralkyl
Prior art date
Application number
HK15103803.4A
Other languages
English (en)
Chinese (zh)
Inventor
‧辛加洛
R‧A‧辛加洛
Original Assignee
得克萨斯州A&M大学系统
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 得克萨斯州A&M大学系统 filed Critical 得克萨斯州A&M大学系统
Publication of HK1203512A1 publication Critical patent/HK1203512A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds
    • C07F9/82—Arsenic compounds containing one or more pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15103803.4A 2006-01-13 2009-09-25 Compounds and methods for the treatment of cancer HK1203512A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75921806P 2006-01-13 2006-01-13
US60/759,218 2006-01-13
US76300806P 2006-01-26 2006-01-26
US60/763,008 2006-01-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK09108874.5A Addition HK1130804B (en) 2006-01-13 2007-01-16 Compounds and methods for the treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK09108874.5A Division HK1130804B (en) 2006-01-13 2007-01-16 Compounds and methods for the treatment of cancer

Publications (1)

Publication Number Publication Date
HK1203512A1 true HK1203512A1 (en) 2015-10-30

Family

ID=38158019

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103803.4A HK1203512A1 (en) 2006-01-13 2009-09-25 Compounds and methods for the treatment of cancer

Country Status (10)

Country Link
US (2) US8222440B2 (enExample)
EP (1) EP1979368B1 (enExample)
JP (1) JP5202332B2 (enExample)
KR (2) KR20130129316A (enExample)
CN (2) CN104109177A (enExample)
AU (1) AU2007204831B2 (enExample)
CA (1) CA2636793C (enExample)
HK (1) HK1203512A1 (enExample)
IL (3) IL192738A0 (enExample)
WO (1) WO2007082104A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009075870A1 (en) * 2007-12-12 2009-06-18 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
NZ591181A (en) 2008-08-20 2012-09-28 Ziopharm Oncology Inc Organoarsenic compounds and methods for the treatment of cancer
US20160304546A1 (en) * 2013-12-05 2016-10-20 Solasia Pharma K.K. Compounds and methods for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1964557B1 (en) 1997-11-10 2013-01-02 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations
EP1002537A1 (en) 1998-10-30 2000-05-24 Assistance Publique, Hopitaux De Paris Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma
EP2420229A1 (en) 2002-01-07 2012-02-22 Board Of Regents, University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
TW201440760A (zh) * 2004-07-16 2014-11-01 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物

Also Published As

Publication number Publication date
CA2636793C (en) 2014-07-08
US20090233894A1 (en) 2009-09-17
CN101395166A (zh) 2009-03-25
WO2007082104A3 (en) 2007-10-18
CN101395166B (zh) 2014-07-09
US8222440B2 (en) 2012-07-17
IL226362A0 (en) 2013-06-27
JP2009527463A (ja) 2009-07-30
AU2007204831A1 (en) 2007-07-19
KR101471498B1 (ko) 2014-12-10
US20130143950A1 (en) 2013-06-06
HK1130804A1 (en) 2010-01-08
WO2007082104A2 (en) 2007-07-19
IL226363A0 (en) 2013-06-27
IL192738A0 (en) 2009-02-11
KR20080106897A (ko) 2008-12-09
CA2636793A1 (en) 2007-07-19
KR20130129316A (ko) 2013-11-27
EP1979368B1 (en) 2014-12-24
AU2007204831B2 (en) 2013-10-03
EP1979368A2 (en) 2008-10-15
CN104109177A (zh) 2014-10-22
JP5202332B2 (ja) 2013-06-05

Similar Documents

Publication Publication Date Title
US11324714B2 (en) Organoarsenic compounds and methods for the treatment of cancer
AU2005274926B2 (en) Compounds and methods for treatment of cancer
HK1203512A1 (en) Compounds and methods for the treatment of cancer
JP2009502971A (ja) がんを治療するための化合物および方法
HK1130804B (en) Compounds and methods for the treatment of cancer
AU2013273809A1 (en) Compounds and methods for the treatment of cancer
HK1157694A (en) Organoarsenic compounds and methods for the treatment of cancer
HK1157694B (en) Organoarsenic compounds and methods for the treatment of cancer
HK1164767B (en) Compounds and methods for the treatment of cancer